Tanner Pharma to Expand Global Access of BOT and BAL with Agenus
Tanner Pharma will manage access to BOT/BAL for patients in geographies that allow named patient access to investigational medicines.
Botensilimab | 13/12/2024 | By Aishwarya | 336
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy